Performance of the SCORTEN During the First Five Days of Hospitalization to Predict the Prognosis of Epidermal Necrolysis
Open Access
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (2) , 272-276
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Toxic Epidermal Necrolysis: Does Immunoglobulin Make a Difference?Journal of Burn Care & Rehabilitation, 2004
- Analysis of Intravenous Immunoglobulin for the Treatment of Toxic Epidermal Necrolysis Using SCORTENArchives of Dermatology, 2003
- Intravenous Immunoglobulin Treatment for Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisArchives of Dermatology, 2003
- SCORTEN: A Severity-of-Illness Score for Toxic Epidermal NecrolysisJournal of Investigative Dermatology, 2000
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- APACHE-II SCORE FOR ASSESSMENT AND MONITORING OF ACUTE PANCREATITISThe Lancet, 1989
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982
- A REVIEW OF GOODNESS OF FIT STATISTICS FOR USE IN THE DEVELOPMENT OF LOGISTIC REGRESSION MODELS1American Journal of Epidemiology, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958